A detailed history of Landmark Financial Advisors, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Landmark Financial Advisors, LLC holds 5,509 shares of JNJ stock, worth $836,651. This represents 0.32% of its overall portfolio holdings.

Number of Shares
5,509
Previous 5,609 1.78%
Holding current value
$836,651
Previous $873,000 1.15%
% of portfolio
0.32%
Previous 0.36%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$145.6 - $158.88 $14,560 - $15,888
-100 Reduced 1.78%
5,509 $863,000
Q3 2023

Oct 13, 2023

SELL
$155.75 - $174.48 $33,797 - $37,862
-217 Reduced 3.72%
5,609 $873,000
Q2 2023

Jul 18, 2023

SELL
$154.35 - $166.11 $128,573 - $138,369
-833 Reduced 12.51%
5,826 $964,000
Q1 2023

Apr 13, 2023

SELL
$151.05 - $180.26 $51,659 - $61,648
-342 Reduced 4.89%
6,659 $1.03 Million
Q4 2022

Jan 23, 2023

SELL
$160.2 - $179.79 $43,574 - $48,902
-272 Reduced 3.74%
7,001 $0
Q3 2022

Nov 10, 2022

BUY
$161.33 - $179.52 $12,583 - $14,002
78 Added 1.08%
7,273 $1.19 Million
Q1 2022

May 16, 2022

BUY
$158.14 - $179.59 $23,879 - $27,118
151 Added 2.14%
7,195 $1.34 Million
Q4 2021

Jan 26, 2022

BUY
$155.93 - $173.01 $651,007 - $722,316
4,175 Added 145.52%
7,044 $1.21 Million
Q3 2021

Nov 12, 2021

SELL
$161.5 - $179.47 $24,871 - $27,638
-154 Reduced 5.09%
2,869 $471,000
Q2 2021

Aug 12, 2021

BUY
$159.48 - $171.07 $24,559 - $26,344
154 Added 5.37%
3,023 $498,000
Q1 2021

May 11, 2021

BUY
$153.07 - $170.48 $34,899 - $38,869
228 Added 8.63%
2,869 $471,000
Q3 2020

Oct 13, 2020

SELL
$140.38 - $153.83 $11,230 - $12,306
-80 Reduced 2.94%
2,641 $391,000
Q2 2020

Jul 17, 2020

BUY
$128.81 - $155.51 $1,545 - $1,866
12 Added 0.44%
2,721 $389,000
Q1 2020

Apr 22, 2020

BUY
$111.14 - $153.99 $53,347 - $73,915
480 Added 21.53%
2,709 $396,000
Q4 2019

Feb 12, 2020

BUY
$127.5 - $146.44 $28,305 - $32,509
222 Added 11.06%
2,229 $331,000
Q3 2019

Nov 07, 2019

SELL
$126.95 - $142.14 $6,347 - $7,106
-50 Reduced 2.43%
2,007 $259,000
Q2 2019

Aug 02, 2019

BUY
$131.15 - $144.24 $6,557 - $7,212
50 Added 2.49%
2,057 $286,000
Q1 2019

May 02, 2019

BUY
$125.72 - $139.79 $880 - $978
7 Added 0.35%
2,007 $280,000
Q4 2018

Feb 05, 2019

BUY
$122.84 - $147.84 $737 - $887
6 Added 0.3%
2,000 $258,000
Q3 2018

Nov 07, 2018

BUY
$121.58 - $142.88 $729 - $857
6 Added 0.3%
1,994 $275,000
Q2 2018

Aug 07, 2018

BUY
$119.4 - $131.76 $955 - $1,054
8 Added 0.4%
1,988 $241,000
Q1 2018

May 01, 2018

BUY
$125.1 - $148.14 $750 - $888
6 Added 0.3%
1,980 $254,000
Q4 2017

Feb 13, 2018

BUY
$131.22 - $143.62 $787 - $861
6 Added 0.3%
1,974 $275,000
Q3 2017

Nov 03, 2017

BUY
$129.47 - $135.38 $776 - $812
6 Added 0.31%
1,968 $256,000
Q2 2017

Aug 11, 2017

BUY
N/A
1,962
1,962 $259,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $397B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Landmark Financial Advisors, LLC Portfolio

Follow Landmark Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Landmark Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Landmark Financial Advisors, LLC with notifications on news.